Moderna claims its Covid vaccine is almost 95% effective

• Live.Coronavirus Spain today, breaking news live

• Prevention: why masks alone will not stop Covid

The American pharmaceutical company

said on Monday that its

vaccine

is 94.5% effective, according to provisional data from its clinical trial, becoming the second American company in a week to report results that far exceed The expectations.

Along with

vaccine

, which has also been shown to be more than 90% effective, and pending more safety data and regulatory review, the

could have two vaccines licensed for emergency use in December with up to 60 million doses vaccine available by the end of the year.

Next year, the US government could have access to

, more than is needed for the country's 330 million residents.

The vaccines, both built with new technology known as

or mRNA, represent powerful new tools to fight a pandemic that has infected 54 million people worldwide and killed 1.3 million.

The news also comes at a time when

cases

are skyrocketing, setting new records in the United States and pushing some European countries back into lockdown.

"We are going to have a vaccine that can stop

" Moderna president

in a telephone interview.

Moderna's interim analysis has been based on 95 infections among trial participants, who received a placebo or the vaccine.

Only five infections occurred among those who received the vaccine, which is given in two injections 28 days apart.

No ultra-cold storage

A key advantage of Moderna's vaccine is that it does not require ultra-cold storage like Pfizer's, making it easy to distribute.

Moderna expects it to be stable at standard temperatures of 2 to 8 degrees for 30 days and can be stored for up to 6 months at -20 degrees.

Pfizer's vaccine should be shipped and stored at minus 70 degrees, the type of temperature typical of an Antarctic winter.

At standard refrigerator temperatures, it can be stored for up to five days.

Data from Moderna's trial with 30,000 participants also shows that the vaccine has prevented

severe

cases

, an issue that has yet to be resolved with the Pfizer vaccine.

Of the 95 cases in Moderna's trial, 11 were severe, and all 11 occurred among volunteers who received the placebo.

Moderna, part of

the US government's

program

, expects to produce about 20 million doses of the vaccine for the United States this year, millions of which the company has already manufactured and is ready to ship if authorized by the US government. regulatory agency

.

"Assuming we get an emergency use authorization, we will be ready to ship through Warp Speed ​​in almost hours," Hoge said.

"So it can start being distributed instantly."

According to the criteria of The Trust Project

Know more

• Vaccinations

• Covid 19

• Coronavirus

• Science and Health

England prepares to vaccinate 1.2 million people a week from December

Pfizer's coronavirus vaccine is not only American, it is born by a couple of researchers of Turkish origin in Germany

HealthRussia says its Sputnik V vaccine against Covid is 92% effective

See links of interest

• News

• Translator

• Programming

• Films

• Topics

• 2021 business calendar

• Coronavirus

• Hereda San Pablo Burgos - Movistar Estudiantes

• Rafael Nadal - Andrey Rublev, live